Peregrine Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,023,882
| Closed | -$11.7M | – | 351 |
|
|
2020
Q4 | $11.7M | Sell |
1,023,882
-93,149
| -8% | -$1.06M | 0.22% | 211 |
|
|
2020
Q3 | $10M | Sell |
1,117,031
-106,247
| -9% | -$956K | 0.27% | 133 |
|
|
2020
Q2 | $12.6M | Sell |
1,223,278
-41,039
| -3% | -$424K | 0.36% | 114 |
|
|
2020
Q1 | $12.8M | Buy |
1,264,317
+4,370
| +0.3% | +$44.1K | 0.46% | 89 |
|
|
2019
Q4 | $16.8M | Sell |
1,259,947
-14,743
| -1% | -$196K | 0.43% | 107 |
|
|
2019
Q3 | $10.9M | Buy |
1,274,690
+41,908
| +3% | +$360K | 0.3% | 134 |
|
|
2019
Q2 | $13.5M | Buy |
+1,232,782
| New | +$13.5M | 0.33% | 129 |
|